Confirmatory Efficacy and Safety Trial of Magnetic Seizure Therapy for Depression (CREST-MST): study protocol for a randomized non-inferiority trial of magnetic seizure therapy versus electroconvulsive therapy
Abstract Background Electroconvulsive therapy (ECT) is well-established and effective for treatment-resistant depression (TRD), but in Canada and the USA, less than 1% of patients with TRD receive ECT mainly due to its cognitive adverse effects (i.e. amnesia). Thus, new treatment alternatives for TR...
Guardado en:
Autores principales: | Zafiris J. Daskalakis, Carol Tamminga, Alanah Throop, Lucy Palmer, Julia Dimitrova, Faranak Farzan, Kevin E. Thorpe, Shawn M. McClintock, Daniel M. Blumberger |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d1003ca162e449d5884898943ebafd36 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Magnetic Seizure Therapy Compared to Electroconvulsive Therapy for Schizophrenia: A Randomized Controlled Trial
por: Jiangling Jiang, et al.
Publicado: (2021) -
Magnetic seizure therapy
por: Rishabh Singh, et al.
Publicado: (2021) -
Risk Assessment of Electroconvulsive Therapy in Clinical Routine: A 3-Year Analysis of Life-Threatening Events in More Than 3,000 Treatment Sessions
por: Vivien L. Hajak, et al.
Publicado: (2021) -
Effects of stimulus parameters on motor seizure duration in electroconvulsive therapy
por: Joo SW, et al.
Publicado: (2017) -
Severity of Depressive Symptoms is Associated with Venous Thromboembolism in Hospitalized Patients with a Major Depressive Episode
por: Yoshizawa K, et al.
Publicado: (2021)